News and views on the clinical trials industry
May 21
Parexel consultant testifies on FDA biosimilars guidance
Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials
To read the full articles for this issue of CWWeekly, please click here for subscription information.
Already a digital subscriber? Access this issue now.
May
Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…
Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…
Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.
Already a digital subscriber? Access this issue now.
